Axim Biotechnologies Inc (OTC: AXIM) is a biotechnology company focused on the research and development of cannabinoid-based therapeutics. The available 10-K filing excerpt (filed 2024-04-16, accession 000109690624000864) does not contain sufficient operational or financial detail to describe a revenue model, product pipeline milestones, customer base, competitive positioning, geographic footprint, or leadership. Based solely on the filing excerpts provided, no further factual claims about the company's business activities, revenue streams, or market position can be supported.

Source: SEC 10-K, filed 2024-04-16

Industry: Pharmaceutical Preparations Peers: Aprea Therapeutics Inc Aridis Pharmaceuticals, Inc. Old Ayala, Inc bioAffinity Technologies Inc Gyre Therapeutics Inc Innovation Pharmaceuticals Inc. Cyclo Therapeutics, Inc. Bio Green Med Solution Inc